about
Insight to drug delivery aspects for colorectal cancerPolymeric micelles in anticancer therapy: targeting, imaging and triggered release.Polypeptide nanogels with hydrophobic moieties in the cross-linked ionic cores: synthesis, characterization and implications for anticancer drug deliveryNanomedicine in GIAdverse drug reaction profile of nanoparticle versus conventional formulation of paclitaxel: An observational studyTargeted albumin-based nanoparticles for delivery of amphipathic drugs.Redox-Responsive Self-Assembled Chain-Shattering Polymeric Therapeutics.Design of polymeric nanoparticles for biomedical delivery applications.Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution.Preparation of chondroitin sulfate-adipic acid dihydrazide-doxorubicin conjugate and its antitumour characteristics against LLC cells.Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosispH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug deliveryEnhanced efficacy against cervical carcinomas through polymeric micelles physically incorporating the proteasome inhibitor MG132Polymeric micelles for neoadjuvant cancer therapy and tumor-primed optical imaging.Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice.Polymeric micelles as a new drug carrier system and their required considerations for clinical trials.Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles.Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.Nanomedicine in cancer therapy: innovative trends and prospects.Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.Biodegradable polymers derived from amino acids.Development of mesoporous silica nanomaterials as a vehicle for anticancer drug delivery.Tailoring polymeric micelles to optimize delivery to solid tumors.Targeting and delivery of platinum-based anticancer drugs.Clinical developments of chemotherapeutic nanomedicines: polymers and liposomes for delivery of camptothecins and platinum (II) drugs.Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines.Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications.Core-shell structured nanoassemblies based on β-cyclodextrin containing block copolymer and poly(β-benzyl L-aspartate) via host-guest complexation.Polymeric micelles for pH-responsive delivery of cisplatin.Polymersomes from polypeptide containing triblock Co- and terpolymers for drug delivery against pancreatic cancer: asymmetry of the external hydrophilic blocks.Multifunctional nanoassemblies of block copolymers for future cancer therapy.Tumor-targeted chemotherapy with the nanopolymer-based drug NC-6004 for oral squamous cell carcinoma.Biocompatibility, absorption and safety of protein nanoparticle-based delivery of doxorubicin through oral administration in rats.N-octyl-N-arginine-chitosan micelles for gambogic acid intravenous delivery: characterization, cell uptake, pharmacokinetics, and biodistribution.Cancer Nanotechnology: Opportunities for Prevention, Diagnosis, and Therapy.
P2860
Q26774682-6EBC4D6D-CFF0-447B-88FB-0FC938FBCC88Q30478123-ACA84D92-74F5-4FE7-996B-5396B5BCA475Q33608893-9F41EBC0-CE86-4B5E-B6F9-B384A163F76AQ34719056-424512DF-7F9A-4710-8E0E-DC8131A9D1BCQ34843961-5B6FCA37-793D-469C-A4EA-37A4DB6B2A23Q35086678-5A54A0B3-E57A-43A0-847D-00343049FD7EQ35801338-73C2153F-53B0-4680-9AE9-F9B5AD7CBB35Q35823338-BFFA5C65-84EE-4B8D-924E-3EE0AD404C1AQ36326953-D0C0C4DA-E9E8-4012-93E2-C2ACE249D79EQ36364124-1E28279A-EEEA-46D7-8F54-974487F9E693Q36579336-4A1BB080-56EF-462E-B2E7-D4651F74A829Q36653608-634C8552-F298-4EEF-8ED9-9608AD53A7B7Q37142449-B5134F23-770C-458E-8ACD-03706513C0AAQ37427858-9DD1DF48-5F08-43AF-B2C9-4911F1ECD601Q37444094-1D2543C8-5395-4B12-8E4E-519F78C46469Q37467770-5BC33B32-6D69-463A-BA81-A3EFB487C5DFQ37679942-921623A8-9A5B-4013-B3A4-203CC4CDB555Q37754141-8EB8F5DF-CC83-43A9-ADE6-523C35931948Q37775972-88048670-38B1-4487-88DC-31D8F6BCA243Q37859080-DB1C4C82-73E7-4284-BECD-4B21B0518485Q37886750-D6DCFB0B-FA25-44E0-AA28-FD5C3843ADA2Q37952641-62B94C1A-B7AE-4ABD-A98E-87128537712DQ38002853-DD00D8ED-44FE-46C8-A4B3-456C3841A8A3Q38038896-EB69311F-5373-4573-A7DE-727E2CEFFF82Q38050063-F4AF2BD9-D5ED-4A1A-906E-2CDEE7F3D556Q38075544-6F7F7DFB-5467-4E9F-A9E1-D850EECEF229Q38105142-58C54AC1-128F-42DB-B728-90740DC1B123Q38263314-EC3B2E80-9E11-4C6B-ADC1-E330C60C8B4EQ38828237-4B01E774-2FB6-4527-80FF-0498CF974762Q38990022-1355D2F8-D7E5-4FA4-A621-F6438A233B57Q38994012-7FB0DF96-E890-45EA-89A1-03F775D47CF2Q39017324-E22F6C2B-57A1-4DBA-A989-A6FD935EABC1Q39231620-BA1ED8CF-A310-47E7-9116-C8EAF9B37B84Q44636337-D390662A-6578-4335-8447-FB2A8921D917Q49499835-1E24B2EF-9604-4B6A-926F-BCFCDDD1064AQ53533429-ACB0A3E8-7905-4A31-980B-4CACFA782499
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Polymeric micellar delivery systems in oncology.
@en
Polymeric micellar delivery systems in oncology.
@nl
type
label
Polymeric micellar delivery systems in oncology.
@en
Polymeric micellar delivery systems in oncology.
@nl
prefLabel
Polymeric micellar delivery systems in oncology.
@en
Polymeric micellar delivery systems in oncology.
@nl
P2860
P356
P1476
Polymeric micellar delivery systems in oncology.
@en
P2093
Yasuhiro Matsumura
P2860
P304
P356
10.1093/JJCO/HYN116
P577
2008-11-06T00:00:00Z